Clinical Trial Update: Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy with prednisone for recurrent/metastatic kidney cancer has completed. The study status is reported as complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Renal Cell Carcinoma

Snippet

Sponsor: University of New Mexico | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED